Click a link below to view the mailing archive as if it had been sent to you.
| 2019-10-31 12:15 | | Pandion, Astellas sign $900m deal for pancreas-targeted immunomodulators and more... |
| 2019-10-31 00:15 | | AbbVie (ABBV) Set to Report Q3 Results: Can Things Turnaround? and more... |
| 2019-10-30 12:15 | | Novartis’ Zolgensma gene therapy study halted by FDA on animal safety concerns and more... |
| 2019-10-30 00:15 | | FDA Ad Com thumbs down on full Makena approval and more... |
| 2019-10-29 12:15 | | Pfizer, GSK, J&J and more strike $248M deal to exit long-running Medicaid fraud suit and more... |
| 2019-10-29 00:15 | | Charities Pay $6 Million to Settle Medicare Kickback Allegations in Pharma Probe and more... |
| 2019-10-28 12:15 | | GlaxoSmithKline kick-starts first-of-its-kind late-stage antibiotic test and more... |
| 2019-10-28 00:15 | | The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings and more... |
| 2019-10-27 00:15 | | A tale of two IPOs (plus one): Cabaletta prices well below range for $75M while Phathom bags $182M and more... |
| 2019-10-26 00:15 | | Smaller, lighter, cheaper: A serial entrepreneur wants his portable MRI to transform medicine and more... |
| 2019-10-25 12:15 | | Most Provocative Statements Heard at MD&M Minneapolis 2019 and more... |
| 2019-10-25 00:15 | | Drugs, data, and the darknet: Cybersecurity a growing threat in the life science and more... |
| 2019-10-24 12:15 | | Lilly counts on growing markets to boost lagging Taltz, Trulicity and more... |
| 2019-10-24 00:15 | | Novartis bets $80M on Pliant's preclinical NASH prospect and more... |
| 2019-10-23 12:15 | | Soriot, Schleifer, Perreault named top global CEOs — but gone are pharma's golden years and more... |
| 2019-10-23 00:15 | | 7 questions on Biogen's revival of a failed Alzheimer's drug and more... |
| 2019-10-22 12:15 | | Biogen resurrects aducanumab, arguing expanded data set supports FDA filing in Alzheimer's and more... |
| 2019-10-22 00:15 | | Researchers Estimate Costs of Exclusivity Extensions to Encourage Antibiotic Development and more... |
| 2019-10-21 12:15 | | Drug distributors and Teva reach tentative settlement of opioids lawsuit and more... |
| 2019-10-21 00:15 | | FDA approves Alexion's Ultomiris for another rare blood disease and more... |
| 2019-10-20 00:15 | | Lawmakers Seek Clarity From FDA on Recall of Lifesaving Drug and more... |
| 2019-10-19 00:15 | | FDA generic approvals hit a new record, but the effort's not paying off yet and more... |
| 2019-10-18 12:15 | | Merck & Co. Eliminating 500 U.S. Sales, Commercial Jobs and more... |
| 2019-10-17 12:15 | | Lawsuit-ridden J&J tumbles in annual listing of best global brands and more... |
| 2019-10-17 00:15 | | Ipsen doubles down on rare bone disease and more... |
| 2019-10-16 00:15 | | Big Pharma Needs A Better Business Model, Not More Legislation and more... |
| 2019-10-15 12:15 | | AbbVie, Gilead and Allergan 3-peat with September's top pharma TV spending and more... |
| 2019-10-15 00:15 | | AZ got past FluMist's efficacy woes, but now it's plagued by production problems and more... |
| 2019-10-14 12:15 | | Staying Ahead of Biosimilar Competition, Roche's Rituxan Shows Superiority in Rare Autoimmune Skin Disease and more... |
| 2019-10-14 00:15 | | Why Amarin Investors Have Their Eyes on Nov. 14 and more... |
| 2019-10-13 00:15 | | Clovis' Rubraca, trailing PARP rivals, nabs England coverage thanks to NICE U-turn and more... |
| 2019-10-12 00:15 | | FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades and more... |
| 2019-10-11 12:15 | | ICER says AbbVie’s Rinvoq for RA may be cost-effective but still questions the value of JAK class and more... |
| 2019-10-11 00:15 | | Bill Gates backs Ginkgo Bioworks' $350M raise to fuel the buzzy synthetic biology 'revolution' and more... |
| 2019-10-10 12:15 | | How Express Scripts Plans to Disrupt the Emerging Cell and Gene Therapy Channel and more... |
| 2019-10-10 00:15 | | Big Pharma giving more money to patient advocacy groups and more... |
| 2019-10-09 12:15 | | Takeda breaks into top 20 largest pharmas with Shire merger and more... |
| 2019-10-09 00:15 | | Johnson & Johnson Ordered To Pay $8 Million In Male Breast Growth Case and more... |
| 2019-10-08 12:15 | | Biopharma M&A: deal-depressed third quarter leaves nowhere to hide and more... |
| 2019-10-08 00:15 | | Recent Job Cuts in the Biopharma Industry and more... |
| 2019-10-07 12:15 | | Oxford spinout MiroBio bags £27M for autoimmune R&D and more... |
| 2019-10-07 00:15 | | It May Be Time For Standard Breast Cancer Treatment To Change and more... |
| 2019-10-06 00:15 | | A Key Novartis Drug Could Be Delayed — Why This Stock Is Cheering and more... |
| 2019-10-05 00:15 | | Nevada Fines Drugmakers $17M for Failing to Comply With Drug Pricing Law and more... |
| 2019-10-04 12:15 | | Dynavax continues to shed staffers as CSO to leave with no replacement plan and more... |
| 2019-10-04 00:15 | | New Study Finds Wider Adoption of Biosimilars Could Save States and Taxpayers Billions and more... |
| 2019-10-03 12:15 | | Gene therapy stocks have taken a beating. Their recovery may be slow and more... |
| 2019-10-03 00:15 | | FDA to Further Investigate Implantable Devices Containing Certain Metals and more... |
| 2019-10-02 12:15 | | ICER pulls report blasting ‘marginal’ RA drugs, citing need to rethink its approach and more... |
| 2019-10-02 00:15 | | 3D-Printed Implants Create Buzz at Annual Spine Meeting and more... |
| 2019-10-01 12:15 | | Novartis and Microsoft announce collaboration to transform medicine with artificial intelligence and more... |
| 2019-10-01 00:15 | | Dana-Farber Study Confirms Accuracy of GRAIL's Blood Test for Cancer and more... |
